As a Nuvaring Pulmonary Embolism, Death and Deep Vein Thrombosis product liability attorney, I have written extensively about the inherent risks associated with oral contraceptive pills containing Drospirenone, like Yaz, Yasmin and Ocella and contraceptive ring like NuvaRing. The first trial for a NuvaRing blood clot lawsuit in the federal Multi-District Litigation (MDL) has been delayed until the summer of 2013.
U.S. District Judge Rodney Sippel, overseeing the consolidated Nuvaring MDL litigation, issued an order for the first NuvaRing trial date to begin on July 8, 2013. This trial date is obviously subject to change depending on the progress of the trial preparation or if a settlement is announced.
What is Nuvaring?
NuvaRing is a birth control ring device that releases female hormones through a plastic ring that is inserted into the vagina once a month. The ring releases estrogen ethinyl estradiol, and a “third-generation” progestin, etonogestrel. Both of these female hormones are associated with an increased risk of blood clots and embolic thrombotic events.
Merck faces more than 1,000 Nuvaring lawsuits
Merck & Co., and their Organon Pharmaceutical subsidiary, are exposed to more than 1,000 lawsuits. These plaintiff women allege that Merck had inadequate warnings about the risk of blood clots from side effects of NuvaRing. These side effects include pulmonary embolism, deep vein thrombosis (DVT), stroke and in extreme cases death.
New Jersey State Complaints against Merck
A number of lawsuits have been filed in New Jersey state court. Merck has its corporate headquarters based in New Jersey, with nearly 200 cases pending. The first New Jersey NuvaRing bellwether trial is expected to begin on February 4, 2013.
What are Bellwether Nuvaring trials?
The trial set in the federal MDL and New Jersey state court litigation, are referred to as “bellwether” trials. These trials are designed to help the parties determine how juries are likely to respond to the similar evidence that will be presented through the litigation.
Judge Sippel has asked the parties to submit plans for alternative dispute resolution to negotiate potential NuvaRing settlement agreements as the first bellwether trial dates approach.
Nuvaring Pulmonary Embolism and Deep Vein Thrombosis Side Effects